The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and Ketoacidosis
Launched by THE SOCIETY OF BARIATRIC AND METABOLIC SURGEONS OF KAZAKHSTAN · Mar 24, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different amounts of carbohydrates in the diet after gastric bypass surgery can affect weight loss and the risk of serious health issues, such as ketoacidosis (a harmful condition caused by high levels of ketones in the body) and liver failure in patients with a liver condition known as nonalcoholic steatohepatitis (NASH). The researchers believe that reducing carbohydrates might help some patients lose weight more effectively, but they also want to understand if it could lead to complications.
To participate in this study, you should be an adult with obesity (a body mass index, or BMI, between 30 and 50) and have NASH. You cannot be actively involved in sports, have diabetes, or cirrhosis (a severe liver condition). If you join the trial, you will be monitored for up to a year to see how different carbohydrate levels in your diet impact your weight loss and health. This trial is currently looking for participants, and all genders are welcome.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • obesity patients BMI 30-50 kg/m2.
- • patients with nonalcoholic steatohepatitis (NASH).
- Exclusion Criteria:
- • patients with active physical sports
- • diabetes
- • cirrhosis
About The Society Of Bariatric And Metabolic Surgeons Of Kazakhstan
The Society of Bariatric and Metabolic Surgeons of Kazakhstan is a leading professional organization dedicated to advancing the field of bariatric and metabolic surgery within the region. Committed to improving patient outcomes, the Society focuses on promoting evidence-based practices, facilitating education and training for healthcare professionals, and fostering collaborative research initiatives. By sponsoring clinical trials, the Society aims to enhance the understanding of bariatric procedures and their impact on metabolic health, ultimately contributing to the development of innovative treatment strategies that address obesity and related conditions in Kazakhstan and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Astana, Aqmola, Kazakhstan
Patients applied
Trial Officials
Oral Ospanov, PhD
Principal Investigator
The Society of Bariatric and Metabolic Surgeons of Kazakhstan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported